Literature DB >> 19464864

Oxidative stress in the pathogenesis of diffuse lung diseases: a review.

E Bargagli1, C Olivieri, D Bennett, A Prasse, J Muller-Quernheim, P Rottoli.   

Abstract

Oxidative stress is an imbalance between oxidants (reactive oxygen and nitrogen species) and antioxidants that may affect lipids, DNA, carbohydrates and proteins. The lung is continuously exposed to endogenous and exogenous oxidants (cigarette smoke, mineral dust, ozone, radiation). Reactive oxygen and nitrogen species are mainly produced by phagocytes as well as by polymorphonuclear, alveolar, bronchial and endothelial cells. A potential role of oxidative stress in the pathogenesis of diffuse lung diseases (particularly idiopathic pulmonary fibrosis) has been demonstrated. Increased oxidant levels and decreased antioxidant defences can contribute to the progression of idiopathic pulmonary fibrosis and other diffuse lung diseases. The growing number of papers on the different aspects of oxidant/antioxidant imbalance in diffuse lung diseases in the last decade reflects increasing interest in this topic and suggests that specific DLDs may be characterized by specific patterns of oxidation and antioxidant responses. The study of oxidative stress can provide insights into etiopathogenesis and favour the discovery of new treatments. In this review of the literature on oxidants and antioxidants in diffuse lung diseases, the focus is on idiopathic pulmonary fibrosis, sarcoidosis, pneumoconiosis and pulmonary fibrosis associated with systemic sclerosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19464864     DOI: 10.1016/j.rmed.2009.04.014

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  55 in total

1.  Oxidative stress destabilizes protein arginine methyltransferase 4 via glycogen synthase kinase 3β to impede lung epithelial cell migration.

Authors:  Xiuying Li; Yandong Lai; Jin Li; Mingyi Zou; Chunbin Zou
Journal:  Am J Physiol Cell Physiol       Date:  2017-06-21       Impact factor: 4.249

2.  Nitrite in exhaled breath condensate as a marker of nitrossative stress in the airways of patients with asthma, COPD, and idiopathic pulmonary fibrosis.

Authors:  Vladimír Rihák; Petr Zatloukal; Jirina Chládková; Alena Zimulová; Zuzana Havlínová; Jaroslav Chládek
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

3.  Enhanced Resolution of Hyperoxic Acute Lung Injury as a result of Aspirin Triggered Resolvin D1 Treatment.

Authors:  Ruan Cox; Oluwakemi Phillips; Jutaro Fukumoto; Itsuko Fukumoto; Prasanna Tamarapu Parthasarathy; Stephen Arias; Young Cho; Richard F Lockey; Narasaiah Kolliputi
Journal:  Am J Respir Cell Mol Biol       Date:  2015-09       Impact factor: 6.914

4.  Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis.

Authors:  Thomas J Richards; Naftali Kaminski; Fred Baribaud; Susan Flavin; Carrie Brodmerkel; Daniel Horowitz; Katherine Li; Jiin Choi; Louis J Vuga; Kathleen O Lindell; Melinda Klesen; Yingze Zhang; Kevin F Gibson
Journal:  Am J Respir Crit Care Med       Date:  2012-01-01       Impact factor: 21.405

5.  Cannabinoid CB1 receptor overactivity contributes to the pathogenesis of idiopathic pulmonary fibrosis.

Authors:  Resat Cinar; Bernadette R Gochuico; Malliga R Iyer; Tony Jourdan; Tadafumi Yokoyama; Joshua K Park; Nathan J Coffey; Hadass Pri-Chen; Gergő Szanda; Ziyi Liu; Ken Mackie; William A Gahl; George Kunos
Journal:  JCI Insight       Date:  2017-04-20

6.  Dysregulation of the glutaredoxin/S-glutathionylation redox axis in lung diseases.

Authors:  Shi B Chia; Evan A Elko; Reem Aboushousha; Allison M Manuel; Cheryl van de Wetering; Joseph E Druso; Jos van der Velden; David J Seward; Vikas Anathy; Charles G Irvin; Ying-Wai Lam; Albert van der Vliet; Yvonne M W Janssen-Heininger
Journal:  Am J Physiol Cell Physiol       Date:  2019-11-06       Impact factor: 4.249

7.  Oxidative stress and inflammation are differentially affected by atorvastatin, pravastatin, rosuvastatin, and simvastatin on lungs from mice exposed to cigarette smoke.

Authors:  Thiago Santos Ferreira; Manuella Lanzetti; Marina Valente Barroso; Carlos Romualdo Rueff-Barroso; Cláudia Farias Benjamim; Lycia de Brito-Gitirana; Luís Cristóvão Porto; Samuel Santos Valença
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

8.  Nrf2 protects against pulmonary fibrosis by regulating the lung oxidant level and Th1/Th2 balance.

Authors:  Norihiro Kikuchi; Yukio Ishii; Yuko Morishima; Yuichi Yageta; Norihiro Haraguchi; Ken Itoh; Masayuki Yamamoto; Nobuyuki Hizawa
Journal:  Respir Res       Date:  2010-03-18

9.  Protective Effect of Infliximab, a Tumor Necrosis Factor-Alfa Inhibitor, on Bleomycin-Induced Lung Fibrosis in Rats.

Authors:  Nejat Altintas; Mustafa Erboga; Cevat Aktas; Bulent Bilir; Murat Aydin; Aysun Sengul; Zehra Ates; Birol Topcu; Ahmet Gurel
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

10.  The glutathione peroxidase 1-protein tyrosine phosphatase 1B-protein phosphatase 2A axis. A key determinant of airway inflammation and alveolar destruction.

Authors:  Patrick Geraghty; Andrew A Hardigan; Alison M Wallace; Oleg Mirochnitchenko; Jincy Thankachen; Leo Arellanos; Victor Thompson; Jeanine M D'Armiento; Robert F Foronjy
Journal:  Am J Respir Cell Mol Biol       Date:  2013-11       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.